Samsung Biologics
Global biopharmaceutical CDMO leader based in South Korea
Company Overview
Samsung Biologics is one of the world's largest contract development and manufacturing organizations (CDMO) for biopharmaceuticals. Headquartered in Incheon, South Korea, the company operates the world's largest biomanufacturing capacity and serves global pharmaceutical clients including major Western pharma companies. Samsung Biologics is expanding into biosimilar development and cell & gene therapy manufacturing, positioning itself at the forefront of APAC's biotech manufacturing ecosystem.
Why This Company Matters
Samsung Biologics is the world's largest contract development and manufacturing organization (CDMO) for biologics, playing a critical role in global pharmaceutical supply chains.
Key Focus Areas
Peer Companies
Doctor Anywhere
Southeast Asia's leading omnichannel healthcare platform
M3 Inc.
Japan's largest digital platform for healthcare professionals
Ping An Good Doctor
China's leading online healthcare services platform powered by AI diagnostics
WuXi Biologics
Leading global CRDMO for biologics drug development and manufacturing
Signal Timeline
0 totalNo signals tracked yet for this company.
Signals will appear here as official announcements are indexed.
We are actively monitoring this company's official channels. Signals will appear as they are discovered.